Showing results (121-130 of 208) with videos related to
Sort By:
Pageof 21
Pediatric Neurology|June 22, 2026
Multiecho Resting-State Functional Magnetic Resonance Imaging Analysis of Attention-Deficit/Hyperactivity Disorder Severity and Motor Dysfunction in a Pediatric Sample of Neurofibromatosis Type 1Mitchell A Batschelett, Karlee Y Migneault, Lindsey Aschbacher-Smith, et al.Frontiers in Neurology|November 10, 2025
Delphi study to elicit expert consensus around decision-making in the treatment of Friedreich ataxiaSheng Han Kuo, Cuixia Tian, James McKay, et al.Journal of Child and Adolescent Psychopharmacology|March 24, 2016
Abnormal Cortical Plasticity in Youth with Autism Spectrum Disorder: A Transcranial Magnetic Stimulation Case-Control Pilot StudyErnest V Pedapati, Donald L Gilbert, Craig A Erickson, et al.Journal of Child and Adolescent Psychopharmacology|April 24, 2025
Determining Clinically Meaningful Improvement in Children and Adolescents with Tourette Syndrome Receiving PharmacotherapyJoseph F McGuire, George B Karkanias, Richard M Bittman, et al.Journal of the American Heart Association|September 27, 2021
The Effect of Adiposity on Cardiovascular Function and Myocardial Fibrosis in Patients With Duchenne Muscular DystrophySarah E Henson, Sean M Lang, Philip R Khoury, et al.Cardiology in the Young|May 13, 2022
Obesity and loss of ambulation are associated with lower extremity oedema in Duchenne muscular dystrophyJoshua M Freytag, Thomas D Ryan, Jean E Bange, et al.Movement Disorders Clinical Practice|May 12, 2025
Safety and Effect of 12-Month Ecopipam Treatment in Pediatric Patients with Tourette SyndromeDonald L Gilbert, David J B Kim, Meredith M Miller, et al.Neurology|July 19, 2019
Motor cortex inhibition and modulation in children with ADHDDonald L Gilbert, David A Huddleston, Steve W Wu, et al.Brain : a Journal of Neurology|June 9, 2006
Dopamine transporter genotype influences the physiological response to medication in ADHDDonald L Gilbert, Zhewu Wang, Floyd R Sallee, et al.Therapeutic Advances in Neurological Disorders|March 2, 2026
Plain Language Summary of a Phase 2b Randomized Controlled Trial of Ecopipam and Its 12-Month Open-Label Extension in Children and Adolescents With Tourette SyndromeDonald L Gilbert, David J B Kim, Meredith M Miller, et al.Pageof 21